Inqaba Biotechnical Industries (Pty) Ltd, trading as inqaba biotec™ in Sub-Saharan Africa, is a unique South African Genomics company that was established in 2002 from an idea that was conceptualized in 2000. Inqaba is Xhosa for “rare and precious” and this pays homage to our South African origin. The company premises are based in Muckleneuk, one of the oldest suburbs in Pretoria. In 2010 the Kenyan subsidiary, inqaba biotec™ East Africa Ltd, was opened in Nairobi and we have registered inqaba biotec™ West Africa Ltd in Nigeria in 2014. The initial startup was organized by a venture team of five, of whom three are still engaged with the company: Dr de Gama, Prof. Göttfert and Dr Preisig.